Word from the Founder

Shaping the Future of Healthcare and Sustainability​

At Advamed Group, our patients, customers, partners, and community are at the heart of everything we do.

Since founding the company in 2010, my mission has been clear—to bridge the gap between cutting-edge medical technology and the people who need it most. It’s not just about distributing products; it’s about delivering solutions that improve lives and ensuring healthcare professionals have the tools to make a real impact.

Omar Elkhatib
Founder/CEO

Leading Healthcare Innovation with Purpose

Advamed is more than a business—it’s a commitment to progress and sustainability. We take pride in our leadership role in the sustainability of medical technology, because we believe in leading by example. Our focus is not just on growth but on creating longterm value for our customers and the communities we serve. We will continue to pursue new discoveries that advance sustainability—ensuring that healthcare remains innovative, accessible, and responsible for future generations.
 

Over the years, we’ve expanded our reach, strengthened our expertise, and built a team of individuals who share the drive to push boundaries. Our success isn’t measured solely by revenue or market share, but by the difference we make in patient outcomes, accessibility, and medical advancements across the region.

Growth is not about following trends; it’s about leading change. We embrace challenges, pioneer innovation, and never settle for “good enough.” With every milestone, we set new benchmarks. With every challenge, we uncover new opportunities.

I am incredibly excited about this journey and truly believe the best of Advamed, Access Medical, and GLE Medical is yet to come.

The future is ours to shape. The ambition never stops.

We will continue to pursue new discoveries that advance sustainability for our customers and for our company.
Omar El Khatib
Founder & CEO

The Advamed Group Story

Transforming Healthcare with
Innovation and Impact

At Advamed Group, we are redefining healthcare by bringing cutting-edge medical solutions to the UAE and Oman. Since 2010, we have partnered with global leaders like Boston Scientific, Abbott, and Edwards Lifesciences, ensuring that hospitals and healthcare providers have access to the latest advancements in cardiology, surgery, and critical care.

 

We are more than distributors; we are drivers of change. Our focus is on innovation, technology, and sustainability, continuously introducing new therapies that improve patient outcomes. Through strong partnerships, advanced digital solutions, and a specialized team, we are shaping the future of healthcare in the region.

The future of healthcare is evolving…

and so are we!

Our Core Values

At Advamed Group, our core values guide us in everything we do, ensuring we deliver exceptional service and drive innovation in healthcare.

Customer First

We always prioritize the needs of healthcare providers and patients.

Integrity

We operate with transparency and ethics in every interaction.

Excellence

We strive for the highest quality in products and services.

Innovation

We embrace new technologies and ideas to stay ahead.

Teamwork

We collaborate as one team across regions, roles, and departments.

People Empowerment

We invest in the development and growth of employees.

Our Milestones

2010

First expansion in the Kingdom of Saudi Arabia.

Nov 09, 2017

2011

Introduction of LAA therapy with Watchman in the Middle East.

Largest worldwide Watchman distributor.

Nov 09, 2017

2013

GLE Medical establishment in Oman.

Introduction of Boston Scientific’s CRM line in Oman.

Nov 09, 2017

2014

Mitral Repair (Cardiac Dimension) introduction in the Gulf region.

Nov 09, 2017

2015

Acquisition of Access Medical UAE.

Partnership with BD for Oman and UAE.

Nov 09, 2017

2016

Partnership with Merit Medical for Oman and UAE.

Nov 09, 2017

2018

Introduction of Mircor in the Middle East.

Partnership with Getinge for Oman.

Nov 09, 2017

2020

Introduction of Shockwave Medical in Oman and UAE.

Nov 09, 2017

2021

Introduction of Boston Scientific’s Interventional.

Cardiology line in Oman.

Nov 09, 2017

2022

Partnership with Edwards Lifescience.

Nov 09, 2017

2023

Introduction of Therakos innovation in Oman.

Distribution agreement for Boston Scientific’s Interventional Oncology line in UAE.

Nov 09, 2017

2024

Partnership with Angiodynamics for Oman and UAE.

Nov 09, 2017

2025

Partnership with Baxter for Oman and UAE.

Nov 09, 2017